Researchers examine the benefits of COVID-19 nasal spray vaccination

A research team at Freie Universität Berlin has conducted a comprehensive comparison of the efficacy of a mucosal, replication-competent but fully attenuated virus vaccine, sCPD9-ΔFCS, with the monovalent mRNA vaccine BNT162b2 in preventing the transmission of SARS-CoV-2 variants.

This post was originally published on this site

Lawyers Lookup -